CJC 1295 / Ipamorelin (No DAC)

10mg · No DAC

$69.00

Lot SC-CJC-2605 · Tested 05.2026 · Stored -20°C / Dry

Purity

≥ 99.0%

Verification

Third-Party HPLC

Ships

3 Business Days

For Research Use Only This product is sold strictly for in vitro laboratory and research applications. Not for human or veterinary use, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease.

Research Overview

A strategic GHRH plus secretagogue blend.

CJC-1295 (No DAC) and Ipamorelin are combined to activate complementary growth hormone pathways. CJC-1295 is a modified GRF analog acting at the GHRH receptor. Ipamorelin is a selective ghrelin receptor agonist with no measured effect on cortisol or prolactin in research settings. Each vial is lyophilized at a 1:1 ratio by weight, sealed, and shipped with a lot-specific Certificate of Analysis.

Specifications

Compound profile.

Blend CJC-1295 (No DAC) + Ipamorelin

Ratio 1:1 by weight

Mass 10mg

Purity ≥ 99.0%

Storage -20°C / Dry

Age Verification

CJC 1295 / Ipamorelin (No DAC)

A strategic GHRH plus secretagogue blend.

Compound profile.

From the catalog.